Evidence map›Paper›PMID 25568133›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Disturbed neuronal ER-Golgi sorting of unassembled glycine receptors suggests altered subcellular processing is a cause of human hyperekplexia.

Natascha Schaefer, Christoph J Kluck, Kerry L Price, Heike Meiselbach, Nadine Vornberger, Stephan Schwarzinger, Stephanie Hartmann, Georg Langlhofer, Solveig Schulz, Nadja Schlegel and 5 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Role of the Glycine Receptor β Subunit in Synaptic Localization and Pathogenicity in Severe Startle Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. Startle Disease: New Molecular Insights into an Old Neurological Disorder.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Anxiety and Startle Phenotypes inFrontiers in molecular neuroscience · 2020
    Article
  13. A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  14. Impaired Glycine Receptor Trafficking in Neurological Diseases.Frontiers in molecular neuroscience · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Natascha SchaeferInstitute for Clinical Neurobiology, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Christoph J KluckInstitute of Biochemistry, Department of Biochemistry and Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kerry L PriceDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.
Heike MeiselbachInstitute of Biochemistry, Bioinformatics Department, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Nadine VornbergerInstitute for Clinical Neurobiology, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Stephan SchwarzingerResearch Center for Bio-Macromolecules and Department of Biopolymers, University Bayreuth, 95447 Bayreuth, Germany.
Stephanie HartmannInstitute of Biochemistry, Department of Biochemistry and Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Georg LanglhoferInstitute for Clinical Neurobiology, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Solveig SchulzCenter of Human Genetics and.
Nadja SchlegelDepartment of Neuropediatrics, Jena University Hospital, 07743 Jena, Germany.
Knut BrockmannInterdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, University Medical Center, Georg August University, 37075 Göttingen, Germany, and.
Bryan LynchTemple Street Children's University Hospital, Dublin, Dublin1, Ireland.
Cord-Michael BeckerInstitute of Biochemistry, Department of Biochemistry and Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Sarah C R LummisDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.
Carmen VillmannInstitute for Clinical Neurobiology, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany, Villmann_C@ukw.de.
University of Würzburg · DEUniversity of Cambridge · GBCenter for Human Genetics · USTemple Street Children's University Hospital · IE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Recent studies on the pathogenic mechanisms of recessive hyperekplexia indicate disturbances in glycine receptor (GlyR) α1 biogenesis. Here, we examine the properties of a range of novel glycine receptor mutants identified in human hyperekplexia patients using expression in transfected cell lines and primary neurons. All of the novel mutants localized in the large extracellular domain of the GlyR α1 have reduced cell surface expression with a high proportion of receptors being retained in the ER, although there is forward trafficking of glycosylated subpopulations into the ER-Golgi intermediate compartment and cis-Golgi compartment. CD spectroscopy revealed that the mutant receptors have proportions of secondary structural elements similar to wild-type receptors. Two mutants in loop B (G160R, T162M) were functional, but none of those in loop D/β2-3 were. One nonfunctional truncated mutant (R316X) could be rescued by coexpression with the lacking C-terminal domain. We conclude that a proportion of GlyR α1 mutants can be transported to the plasma membrane but do not necessarily form functional ion channels. We suggest that loop D/β2-3 is an important determinant for GlyR trafficking and functionality, whereas alterations to loop B alter agonist potencies, indicating that residues here are critical elements in ligand binding.

Indexed as

Amino Acid SequenceAnimalsChildChlorocebus aethiopsCOS CellsEndoplasmic ReticulumFemaleGolgi ApparatusHEK293 CellsHumansInfantIntracellular SpaceMaleMiceMolecular Sequence DataNeuronsReceptors, Glycineassemblybiogenesisglycine receptorhuman hyperekplexiarescue of functionsubcompartimentalization

Identifiers

PMID25568133
PMCPMC4287157
OpenAlexW2027784769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.